Kensington Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Buy
39,225
+879
+2% +$101K 2.27% 17
2025
Q4
$4.04M Buy
38,346
+2,547
+7% +$239K 1.64% 22
2025
Q3
$3M Sell
35,799
-7,691
-18% -$633K 1.22% 26
2025
Q2
$3.44M Buy
43,490
+1,256
+3% +$99.8K 1.48% 23
2025
Q1
$3.79M Buy
42,234
+2,680
+7% +$250K 1.68% 19
2024
Q4
$3.93M Buy
39,554
+1,324
+3% +$136K 1.64% 18
2024
Q3
$4.34M Buy
38,230
+550
+1% +$65.3K 1.81% 16
2024
Q2
$4.66M Buy
37,680
+1,334
+4% +$172K 2.06% 10
2024
Q1
$4.8M Buy
36,346
+1,286
+4% +$159K 2.19% 11
2023
Q4
$3.82M Buy
35,060
+5,393
+18% +$560K 2% 12
2023
Q3
$3.05M Buy
29,667
+2,226
+8% +$240K 1.9% 13
2023
Q2
$3.17M Buy
27,441
+3,369
+14% +$383K 2.01% 9
2023
Q1
$2.56M Sell
24,072
-1,309
-5% -$141K 1.93% 15
2022
Q4
$2.82M Buy
25,381
+252
+1% +$25.8K 2.21% 8
2022
Q3
$2.16M Buy
25,129
+1,291
+5% +$115K 1.82% 13
2022
Q2
$2.17M Sell
23,838
-368
-2% -$32.6K 1.85% 11
2022
Q1
$1.99M Buy
24,206
+1,251
+5% +$98.6K 1.31% 27
2021
Q4
$1.76M Buy
+22,955
New +$1.83M 1.03% 49
2021
Q2
$1.9M Sell
24,395
-747
-3% -$55.6K 1.3% 29
2021
Q1
$1.85M Buy
25,142
+2,474
+11% +$182K 1.39% 24
2020
Q4
$1.77M Buy
+22,668
New +$1.73M 1.46% 18

Other funds holding MRK

Kensington Investment Counsel's MRK Position: Q1 2026 in Review

Kensington Investment Counsel increased its Merck (MRK) stake by 2.3% in Q1 2026, buying an estimated $101K and bringing the position to 39,225 shares worth $4.72M. The position accounts for 2.27% of the portfolio, ranked #17.

Kensington Investment Counsel first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.8M in Q1 2024. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kensington Investment Counsel held 39,225 shares of Merck worth $4.72M as of Q1 2026.
  • Kensington Investment Counsel bought 879 Merck shares in Q1 2026, an estimated $101K.
  • Merck made up 2.27% of Kensington Investment Counsel's portfolio in Q1 2026, its #17 holding.
  • Kensington Investment Counsel first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
  • Kensington Investment Counsel's Merck position peaked at $4.8M in Q1 2024.
  • 3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.